Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Adapalene

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    18 result(s) found for: Adapalene. Displaying page 1 of 1.
    EudraCT Number: 2006-004215-21 Sponsor Protocol Number: RD.06.SPR.18088 Start Date*: 2006-12-19
    Sponsor Name:Galderma Research & Development Inc.
    Full Title: A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO DEMONSTRATE THE EFFICACY AND SAFETY OF ADAPALENE/BENZOYL PEROXIDE TOPICAL GEL COMPARED WITH ADAPALENE TOPICAL GEL, 0.1%; BENZOYL PE...
    Medical condition: Acne Vulgaris Treatment
    Disease: Version SOC Term Classification Code Term Level
    8.1 10000519 Acne vulgaris LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-000475-25 Sponsor Protocol Number: SPON489-07 Start Date*: 2009-11-10
    Sponsor Name:Cardiff University
    Full Title: Randomised, controlled, double-blind, parallel group clinical trial evaluating the efficacies and safety of methyl-aminolevulinate photodynamic therapy and intense pulsed light, administered as pl...
    Medical condition: Mild to moderate acne vulgaris in adult patients.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-006792-68 Sponsor Protocol Number: RD.03.SPR.29080-DE Start Date*: 2009-08-04
    Sponsor Name:Galderma Research & Development
    Full Title: Efficacy and Safety comparison of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel associated with Lymecycline 300mg Capsules versus Adapalene 0.1% / Benzoyl Peroxide 2.5% Vehicle Gel associated with Lym...
    Medical condition: Moderate to severe acne vulgaris on the face
    Disease: Version SOC Term Classification Code Term Level
    9.1 10000519 Acne vulgaris LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: DE (Completed) FR (Completed) BE (Completed) SE (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2006-004278-28 Sponsor Protocol Number: RD.03.SPR.29058 Start Date*: 2007-02-26
    Sponsor Name:GALDERMA Research & Development
    Full Title: Efficacy and Safety of a Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel Compared to Clindamycin 1% / Benzoyl Peroxide 5% Gel in the Treatment of Acne Vulgaris
    Medical condition: Treatment of acne vulgaris
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: GB (Completed) DE (Completed) ES (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2005-004708-35 Sponsor Protocol Number: S194-SP-05 Start Date*: 2007-07-06
    Sponsor Name:Laboratorios Stiefel (España), S.A.
    Full Title: A Multi-Centre, Comparative, Randomized, Single-Blind, Parallel Group, Clinical Trial in Phase IV for the Evaluation of the Subjects Quality of Life, the Efficacy and the Tolerance of Duac® Gel (a ...
    Medical condition: Treatment of acne vulgaris from mild to moderate severity.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10000519 Acne vulgaris LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: PT (Not Authorised)
    Trial results: (No results available)
    EudraCT Number: 2004-002272-41 Sponsor Protocol Number: S194-INT-04 Start Date*: 2004-12-07
    Sponsor Name:Stiefel Laboratories International Division
    Full Title: A Multi-Centre, Single-Blind, Parallel Group, Clinical Evaluation of the Efficacy and Safety of Duac Gel (A Gel containing Clindamycin Phosphate [Equivalent to 1% Clindamycin] and 5% Benzoyl Peroxi...
    Medical condition: Acne Vulgaris
    Disease: Version SOC Term Classification Code Term Level
    10000519
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-011212-37 Sponsor Protocol Number: RD.03.SPR.29084 Start Date*: 2010-01-06
    Sponsor Name:Galderma research & Development
    Full Title: Anti P. acnes activity of Epiduo® Gel compared to Benzoyl Peroxide 2.5% Gel in the treatment of subjects with acne vulgaris
    Medical condition: Acne vulgaris with a high level of P. Acnes on the face (obeserved under wood's lamp)
    Disease: Version SOC Term Classification Code Term Level
    12.0 10000519 Acne vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: PL (Completed)
    Trial results: View results
    EudraCT Number: 2017-001575-23 Sponsor Protocol Number: 201884 Start Date*: 2017-09-21
    Sponsor Name:GlaxoSmithKline KK
    Full Title: Clinical evaluation of efficacy at 2 weeks of Duac fixed dose combination gel in treatment of facial acne vulgaris in Japanese Subjects.
    Medical condition: Acne vulgaris
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000018399 10000519 Acne vulgaris LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2021-000100-37 Sponsor Protocol Number: V01-126A-202 Start Date*: 2022-01-03
    Sponsor Name:Bausch Health Americas, Inc.
    Full Title: A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Clinical Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel (0.3% adapalene/2.5% BPO), in the Treat...
    Medical condition: Acne Vulgaris
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004858 10000519 Acne vulgaris LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-002975-25 Sponsor Protocol Number: 59325 Start Date*: 2017-11-23
    Sponsor Name:Bispebjerg Hospital
    Full Title: Multimodal optical imaging for pretreatment evaluation for cutaneous microparticle delivery
    Medical condition: Facial acne vulgaris lesions after pretreatment with topical retinoid
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004858 10000519 Acne vulgaris LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2016-000063-16 Sponsor Protocol Number: RD.03.SPR.109807 Start Date*: 2016-06-10
    Sponsor Name:Galderma R&D SNC
    Full Title: Efficacy and safety of CD5024 1% in acne vulgaris
    Medical condition: Acne vulgaris
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004858 10000519 Acne vulgaris LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-014550-14 Sponsor Protocol Number: DPSI-Acanya-P4-02 / 290622BS Start Date*: 2009-09-25
    Sponsor Name:Dow Pharmaceutical Sciences, Inc on behalf of Coria Laboratories
    Full Title: A single center, randomized, controlled study to determine the irritant potential of topical acne formulations on intact healthy skin on the back following repeated application during a 21-day trea...
    Medical condition: Cumulative irritation test
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-020796-24 Sponsor Protocol Number: DPSI-Acanya-P4-03 / 300108BS Start Date*: 2010-10-13
    Sponsor Name:Dow Pharmaceutical Sciences, Inc
    Full Title: A multi-center, randomized, observer-blind trial to compare the irritant potential of the two topical acne formulations Acanya® Gel and Epiduo® Gel on acneic skin in a split-face assessment during ...
    Medical condition: Subjects with facial acne
    Disease: Version SOC Term Classification Code Term Level
    13.1 10040785 - Skin and subcutaneous tissue disorders 10000519 Acne vulgaris LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-004606-24 Sponsor Protocol Number: 04.168-11 Start Date*: 2005-01-24
    Sponsor Name:Fujisawa GmbH
    Full Title: A randomized, open-label, monocentric clinical phase I/IV study in healthy human volunteers to evaluate the skin tolerability and cosmetic acceptance of three marketed anti-acne drugs (Differin® Cr...
    Medical condition:
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-004339-23 Sponsor Protocol Number: 63393/H Start Date*: 2006-01-26
    Sponsor Name:Gedeon Richter Co.
    Full Title: Cink-hyaluronát (Curiosin®) gél és adapalen (Differin®) gél kezelés hatása az életminőség alakulására és a két gyógyszerkészítmény összehasonlító tolerabilitási vizsgálata acnes betegeken.
    Medical condition: Acne Leeds 1B-1C-1D-1E-1F
    Disease: Version SOC Term Classification Code Term Level
    8.0 10000496 PT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: View results
    EudraCT Number: 2008-007981-44 Sponsor Protocol Number: RD.03.SPR.40076E Start Date*: 2009-03-12
    Sponsor Name:GALDERMA R&D SNC
    Full Title: EXPLORATORY STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CD5789 IN SUBJECTS WITH ACNE
    Medical condition: Acne vulgaris
    Disease: Version SOC Term Classification Code Term Level
    9.1 10000519 Acne vulgaris LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2014-002509-39 Sponsor Protocol Number: RD.03.SPR.102710 Start Date*: 2014-10-30
    Sponsor Name:GALDERMA R&D
    Full Title: Effect of Patient Education on Treatment Adherence and Satisfaction among Acne Patients Receiving Once-Daily EpiduoTM Gel Treatment in Primary Care Clinics
    Medical condition: Acne vulgaris
    Disease: Version SOC Term Classification Code Term Level
    17.0 10040785 - Skin and subcutaneous tissue disorders 10040785 Skin and subcutaneous tissue disorders SOC
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-002359-26 Sponsor Protocol Number: S194-401 Start Date*: 2008-11-19
    Sponsor Name:Stiefel Laboratories
    Full Title: A multi-center, randomized, evaluator-blind, parallel group study evaluation of the efficacy, safety, and tolerability of DUAC® Akne Gel and Epiduo® Gel in the topical treatment of facial acne vu...
    Medical condition: acne vulgaris
    Disease: Version SOC Term Classification Code Term Level
    9.1 10000519 Acne vulgaris LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 20 02:21:01 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA